Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as $3.48 and last traded at $3.51, with a volume of 189335 shares traded. The stock had previously closed at $3.65.
Evotec Stock Down 3.8 %
The business’s 50 day moving average is $3.68 and its 200-day moving average is $5.00. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of 8.90 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Trading Stocks: RSI and Why it’s Useful
- Why Lennar Stock Could Be the Best Play in the Housing Market
- ETF Screener: Uses and Step-by-Step Guide
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to buy stock: A step-by-step guide for beginners
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
